# FDA recall D-682-2014

> **Aidapak Services, LLC** · Class II · drug recall initiated 2013-07-02.

## Product

guaiFENesin ER, Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824000815

## Reason for recall

Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: AD21965_13, EXP: 5/1/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD56917_7, EXP: 5/21/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD73627_17, EXP: 5/30/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: W003216

## Distribution

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

## Key facts

- **Recall number:** D-682-2014
- **Recalling firm:** Aidapak Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-02
- **Report date:** 2014-01-22
- **Termination date:** 2014-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vancouver, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-682-2014

## Citation

> AI Analytics. FDA recall D-682-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-682-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*